Sjövall J, Westerlund D, Alván G
Br J Clin Pharmacol. 1985 Feb;19(2):191-201. doi: 10.1111/j.1365-2125.1985.tb02631.x.
The aim of this study was to determine whether concentration-dependent renal clearance of ampicillin and amoxycillin occurs. The drugs were given as single 20 min i.v. infusions in doses ranging from 1.9 to 2.8 g to nine healthy volunteers using a cross-over design. Plasma and urinary concentrations were determined by a selective liquid chromatographic method using frequent sampling up to 10 and 30 h respectively after termination of the infusion. The renal clearance of the drugs was independent of the plasma concentration. The mean (s.d.) renal clearances of ampicillin and amoxycillin were 167 (24) and 157 (20) ml min-1 1.73 m-2 respectively. The net secretion was about 50% of the total renal clearance of both drugs. The plasma concentration and urinary excretion rate versus time curves indicated a polyexponential decline, which could be described by both a biexponential and a triexponential equation. The former proved to be more reliable, especially in the calculation of micro rate constants. There was a tendency to more sustained plasma concentrations after amoxycillin, also illustrated by a significantly lower mean (s.d.) plasma clearance of this drug, viz. 185 (30) ml min-1 1.73 m-2, as compared to ampicillin, 210 (24) ml min-1 1.73 m-2 (P less than 0.04). There were no major differences in the disposition rate constants and the distribution volumes of ampicillin and amoxycillin. The mean (s.d.) plasma half-life was 1.7 (0.3) h for both drugs. The urinary excretion rate indicated a slower terminal disposition rate however, with ampicillin and amoxycillin half-lives of 3.4 (2.0) and 3.9 (1.2) h respectively. The longer half-life in the terminal phase may be due to increased tubular reabsorption at low urinary concentrations. It was not possible to determine in this study whether the half-life was affected by changes in clearance or volume of distribution. The urinary solubility of the drugs was dependent on pH. This could explain the massive macroscopic crystalluria seen in one subject after amoxycillin. Three hours after termination of the infusion, crystals could no longer be found in the sediment. There was no clinical or laboratory evidence of renal damage.
本研究的目的是确定氨苄西林和阿莫西林的肾清除率是否存在浓度依赖性。采用交叉设计,对9名健康志愿者以1.9至2.8 g的剂量进行单次20分钟静脉输注给药。分别在输注结束后长达10小时和30小时通过选择性液相色谱法并频繁采样来测定血浆和尿液浓度。药物的肾清除率与血浆浓度无关。氨苄西林和阿莫西林的平均(标准差)肾清除率分别为167(24)和157(20)ml·min⁻¹·1.73 m⁻²。两种药物的净分泌量约占总肾清除率的50%。血浆浓度和尿排泄率随时间变化的曲线呈多指数下降,可用双指数方程和三指数方程来描述。前者被证明更可靠,尤其是在计算微速率常数时。阿莫西林给药后血浆浓度有更持久的趋势,这也通过该药物显著更低的平均(标准差)血浆清除率得以体现,即185(30)ml·min⁻¹·1.73 m⁻²,而氨苄西林为210(24)ml·min⁻¹·1.73 m⁻²(P<0.04)。氨苄西林和阿莫西林在处置速率常数和分布容积方面没有重大差异。两种药物的平均(标准差)血浆半衰期均为1.7(0.3)小时。然而,尿排泄率显示终末处置速率较慢,氨苄西林和阿莫西林的半衰期分别为3.4(2.0)小时和3.9(1.2)小时。终末相半衰期较长可能是由于低尿浓度时肾小管重吸收增加。在本研究中无法确定半衰期是否受清除率或分布容积变化的影响。药物的尿溶解度取决于pH值。这可以解释一名受试者在服用阿莫西林后出现的大量肉眼可见的结晶尿。输注结束3小时后,沉淀物中不再能发现晶体。没有肾损伤的临床或实验室证据。